CD99 reactivity in mesenchymal chondrosarcoma

Human Pathology

Volumn 27, Issue 12, 1996, Pages 1273-1276

  Granter, Scott R ^a,b   Renshaw, Andrew A ^a   Fletcher, Christopher D M ^a   Bhan, Atul K ^a   Rosenberg, Andrew E ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

CD99; Ewing's sarcoma; immunohistochemistry; mesenchymal chondrosarcoma; MIC2; O13; primitive neuroectodermal tumors

Indexed keywords

MONOCLONAL ANTIBODY;

ADOLESCENT; ADULT; ANTIGEN ANTIBODY REACTION; ARTICLE; CHONDROSARCOMA; CLINICAL ARTICLE; EWING SARCOMA; FEMALE; HUMAN; IMMUNOHISTOCHEMISTRY; IMMUNOHISTOLOGY; IMMUNOREACTIVITY; MALE; NEUROECTODERM TUMOR; TUMOR DIAGNOSIS;

EID: 0029807999     PISSN: 00468177     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0046-8177(96)90336-6     Document Type: Article

References (22)

1. MIC2) neuroectodermal/Ewing's sarcoma antigen as an immunohistochemical marker. Appl Immunohistochem 2:231-240, 1994
2. MIC2 and is useful in diagnosing Ewing's sarcoma and peripheral neuroepithelioma. Am J Surg Pathol 18:486-494, 1994
3. Ambros IM, Ambros PF, Strehl S, et al: MIC2 is a specific marker for Ewing's sarcoma and peripheral primitive neuroectodermal tumors. Cancer 67:1886-1893, 1991
4. MIC2. Am J Pathol 139:317-325, 1991
5. Renshaw AA: O13 (CD99) in Spindle cell tumors: Reactivity with hemangiopericytoma, solitary fibrous tumor, synovial sarcoma, and meningioma but rarely with sarcomatoid mesothelioma. Appl Immunohistochem 3:250-256, 1995
6. MIC2 (CD99) in synovial sarcoma. Appl Immunohistochem 3:168-173, 1995
7. Fellinger EJ, Garin-Chesa P, Su SL, et al: Biochemical and genetic characterization of the HBA71 Ewing's sarcoma cell. Cancer Res 51:336-340, 1991
8. MIC2), neuron specific enolase, and vimentin in the immunohistochemical analysis of Ewing's sarcoma of bone. Am J Surg Pathol 16:746-755, 1992
9. Rettig WJ, Garin-Chesa P, Huvos AG: Ewing's sarcoma: New approaches to histogenesis and molecular plasticity. Lab Invest 66:133-137, 1992
10. Garin-Chesa P, Swanson PE, Rettig WJ, et al: Immunohistochemical analysis of small round cell tumors for expression of the MIC2 gene product. Mod Pathol 6:6A, 1993 (abstr 15)
11. Nakashima Y, Unni KK, Shives TC, et al: Mesenchymal chondrosarcoma of bone and soft tissue: A review of 111 cases. Cancer 57:2444-2453, 1986
12. Riopel M, Dickman PS, Link MP, et al: MIC2 analysis in pediatric lymphomas and leukemias. HUM PATHOL 25:396-399, 1994
13. Dickersin GR, Rosenberg AE: The ultrastructure of small-cell osteosarcoma, with a review of the light microscopy and differential diagnosis. HUM PATHOL 22:267-275, 1991
14. Huvos AG, Rosen G, Dabska M, et al: Mesenchymal chondrosarcoma: A clinicopatholgic analysis of 35 patients with emphasis on treatment. Cancer 51:1230-1237, 1983
15. Dabska M, Huvos AG: Mesenchymal chondrosarcoma in the young. Virchows Arch 399:89-104, 1983
16. Harwood AR, Krajbich JI, Fornasier VL: Mesenchymal chondrosarcoma: A report of 17 cases. Clin Orthop 158:144-148, 1981
17. Rosen G, Caparros B, Nirenberg A, et al: Ewings sarcoma: Ten-year experience with adjuvant chemotherapy. Cancer 47:2204-2213, 1981
18. Devaney K, Abbondanzo SL, Shekitka KM, et al: MIC2 detection in tumors of bone and adjacent soft tissue. Clin Orthop Rel Res 310:176-187, 1995
19. Devaney K, Vinh TN, Sweet DE: Small cell osteosarcoma of the bone: An immunohistochemical study with differential diagnostic considerations. HUM PATHOL 24:1211-1225, 1993
20. Cooper K, Haffajee Z: Immunohistochemical assessment of MIC2 gene product in granulocytic sarcoma using six epitope retrieval systems. Appl Immunohistochem 3:198-201, 1995
21. Sainati L, Scapinello A, Montaldi A, et al: A mesenchymal chondrosarcoma of a child with the reciprocal translocation t(11;22) (q24;q12). Cancer Genet Cytogenet 71:144-147, 1993
22. Goji J, Sano K, Nakamura H, et al: Chodrocytic differentiation of peripheral neuroectodermal tumor cell line in nude mouse xenograph. Cancer Res 52:4214-4220, 1992